Your SlideShare is downloading. ×
Venture Capital Firms
Venture Capital Firms
Venture Capital Firms
Venture Capital Firms
Venture Capital Firms
Venture Capital Firms
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Venture Capital Firms

1,599

Published on

Published in: Economy & Finance, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,599
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
23
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. 2005 Biotechnology Venture Capital Guide A____________________ Venture Capital Firms A/S Dansk Erhvervsinvestering Bergensgade 10 3i Group plc Copenhagen Ø, Denmark DK-2100 Ph: +(45) 35468600 91 Waterloo Road Fax: +(45) 35438602 London, United Kingdom SE1 8XP Web: www.dan-erhv.dk Ph: +(44) 2079283131 E-mail: info@dan-erhv.dk Fax: +(44) 2079280058 Web: www.3i.com Company Contacts E-mail: london@3i.com Lauritsen, Jesper President Company Contacts jb@dan-erhv.dk Fraser, Andrew Director, Healthcare, UK Hemmingsen, Steen Senior Investment Manager Hargreaves, Brian Global Sector Head, Healthcare Korsgaard, Tyge Vice President Schlick, Eric Head, German Healthcare Team Holck-Andersen, Birgitte Investment Manager Gillin, Arne Director, Healthcare, Nordic Biotechnology Portfolio 3D - Danish Diagnostic Development A/S; ACE Biosciences MacKay, Alan A/S; Adept Technology A/S; DNA Technology A/S; Genmab Managing Director A/S; Inoxell A/S; Leukotech A/S; NatImmune A/S; NeuroSearch A/S; NsGene A/S; Santaris Pharma A/S; Biotechnology Portfolio Sophion Bioscience A/S; TTM A/S; Zealand Actelion Pharmaceuticals Inc.; Arrow Therapeutics; Pharmaceuticals A/S; Zgene A/S Biosearch Italia SPA; Cambridge Antibody Technology; Celltech; Crucell NV; Evotec Neurosciences GmbH; Stages Funded Genesto A/S; Gyros AB; IDEA AG; Igeneon; Intercytex Ltd.; Seed, Series A-B, Series C-D, Buyout Novuspharma; Shire Pharmaceuticals Stages Funded Areas of Focus Therapeutics, Diagnostics, Medical devices, Regional Seed, Series A-B, Series C-D, Mezzanine, Bridge, Buyout investment Areas of Focus Therapeutics, Vaccines, Diagnostics, Medical devices, Chemicals/reagents/supplies BioAbility® and BioWorld® 1
  • 2. 2005 Biotechnology Venture Capital Guide Abingworth Management Ltd. ABN AMRO Capital France 38 Jermyn Street Venture Capital London, United Kingdom SW1Y 6DN 23 rue Balzac Ph: +(44) 2075341500 Paris, France F-75008 Fax: +(44) 2072870480 Ph: +(33) 153936908 Web: www.abingworth.com Fax: +(33) 153936920 E-mail: info@abingworth.com Web: www.abnamroventure.fr Company Contacts Company Contacts Abell, James Agrech, Dominique Director and Chief Financial Officer dagrech@abnamroventure.fr abell@abingworth.co.uk Rose, Nicolas Berriman, John nrose@abnamroventure.fr Director berriman@abingworth.co.uk Moatti, Olivier omoatti@abnamroventure.fr Leathers, David Director Svensson, Magdalena leathers@abingworth.co.uk msvensson@abnamroventure.fr Bunting, Stephen Biotechnology Portfolio Managing Director Acteon; BioAlliance Pharma SA; DrugAbuse Sciences; bunting@abingworth.co.uk HemoSystem; Neurotech SA; Satelec Pierre-Rolland Shields, John Assistant Director ABN AMRO Capital Gesellschaft für shields@abingworth.co.uk Beteiligungsberatung mbH Biotechnology Portfolio Theodor-Heuss-Allee 80 3-Dimensional Pharmaceuticals; Adiana; Alkermes; Allos Frankfurt am Main, Germany D-60486 Therapeutics; Alnylam Pharmaceuticals Inc.; Akubio; Ph: +(49) 6926900424 Argomed Inc.; Astex Technology; Aurora Biosciences; Fax: +(49) 6926900429 Aviron Inc.; BioImage; Cantab Pharmaceuticals; Chroma Web: www.abnamro.de Therapeutics; Clinical Designs; DevGen NV; Dura E-mail: aacapital.frankfurt@de.abnamro.com Pharmaceuticals; Entelos; Epigenomics; Galápagos Genomics; GelTex Pharmaceuticals; GenPharm; GeneMedicine; Genetic Therapy; Gilead Sciences; Guava Technologies; Healtheon; Hexagen; Hydra Biosciences; Iconix Pharmaceuticals; IDEC Pharmaceuticals; Inpharmatica Ltd.; Interventional Technologies; Labcyte; Lorantis Holdings Ltd.; Micromet AG; Molecular Dynamics; Neurocrine Biosciences; Neurogen; Oxagen; ParAllele BioScience; Pharmacopeia; Pharmion; Phoqus Pharmaceuticals; Picoliter; Portola Pharmaceuticals; Protein Mechanics; Quantum Dot; Ribopharma AG; Sensors for Medicine and Science; Solexa; Sunesis Pharmaceuticals; Versicor; XCounter AB; Xenogen Corporation Stages Funded Seed, Series A-B, Series C-D Areas of Focus Therapeutics, Vaccines, Diagnostics, Medical devices, Platform technologies 2 BioAbility® and BioWorld®
  • 3. 2005 Biotechnology Venture Capital Guide Adamant Biomedical Investments Ltd. ADENA Technologie-Beteiligungen GmbH & Aeschenvorstadt 55 Co. KG Basel, Switzerland CH-4051 Hessenring 71 Ph: +(41) 612759200 Bad Homburg, Germany D-61348 Fax: +(41) 612759201 Ph: +(49) 6172673460 Web: www.adamantinvest.com Fax: +(49) 6172673467 E-mail: info@adamantinvest.com Web: http://www.adanac.de E-mail: info@adanac.de Company Contacts Frey, Nora Company Contact Managing Director Bischoff, Andrea Kreider, Eunice Senior Research Analyst Biotechnology Portfolio aminoNova AG; Coripharm Medizinprodukte GmbH & Meckler, Phillip Company KG Partner Stages Funded Zimmermann, Cyrill Seed, Mezzanine Partner Areas of Focus Biotechnology Portfolio Diagnostics, Medical devices Amgen; Cephalon Inc.; Gilead Sciences Inc.; Ligand Pharmaceuticals; Micromet AG; Neurocrine Biosciences Inc. AdVal Capital Management AG Stages Funded Suessenguthstrasse 1a Mezzanine, Bridge Munich, Germany D-81247 Ph: +(49) 894556580 Areas of Focus Fax: +(49) 8945565879 Therapeutics, Vaccines, Medical devices Web: www.adval.de E-mail: info@adval.de Adams Street Partners Ltd. Company Contacts Käss, Robert 20 Grosvenor Place Board of Directors London, United Kingdom SW1X 7HN robert.kaess@adval.de Ph: +(44) 2078230640 Fax: +(44) 2078230659 Pfender, Stefan Web: www.adamsstreetpartners.com Investment Board E-mail: info@adamsstreetpartners.com stefan.pfender@adval.de Company Contacts Lindner, Ines Smits, Hanneke Investment Manager hsmits@adamsstreetpartners.com ines.lindner@adval.de Sheshuryak, Sergey Lehner, Markus Investment Manager Biotechnology Portfolio markus.lehner@adval.de Aviron Inc.; BioMedicines Inc.; CardioVention Inc.; Combichem Inc.; CombinatoRx Inc.; Depotech Corporation; Rudat, Gudrun Eligix; Galileo Pharmaceuticals Inc.; Heartport; IntraBiotics Assistant Pharmaceuticals Inc.; Jazz Pharmaceuticals Inc.; Myogen gudrun.rudat@adval.de Inc.; NxStage Medical Inc.; Pharmacyclics Inc.; Revivant Corporation; Scientific Protein Labs; Sensys Medical; Biotechnology Portfolio Somatogen Inc.; Spinal Dynamics Corporation; Vivant LinoDiagnostic AG Medical Inc. Stages Funded Stages Funded Seed, Series A-B, Mezzanine Series A-B, Series C-D, Mezzanine, Bridge, Buyout Areas of Focus Therapeutics, Vaccines, Medical devices, Chemicals/reagents/supplies BioAbility® and BioWorld® 3
  • 4. 2005 Biotechnology Venture Capital Guide Advantec Unternehmensbeteiligungen AG Advent International plc – United Kingdom Grunewaldstrasse 22 Headquarters Berlin, Germany D-12165 123 Buckingham Palace Road Ph: +(49) 302190880 London, United Kingdom SW1W 9SL Fax: +(49) 3021908890 Ph: +(44) 2073330800 Web: www.advantec.net Fax: +(44) 2073330801 E-mail: berlin@advantec.net Web: www.adventinternational.com E-mail: info@uk.adventinternational.com Company Contacts Matthies, Peter Company Contact Management Consultant Pope, Rory Principal Buchner, Harald rpope@uk.adventinternational.com Maier, Dieter Biotechnology Portfolio Achillion Pharmaceuticals Inc.; AeroGen Inc.; AlgoRx Biotechnology Portfolio Pharmaceuticals Inc.; Anadys Pharmaceuticals Inc.; Ardais Bioptic Lasersysteme AG; Roboscreen GmbH; VisionLab Corporation; Array BioPharma Inc.; Arris Pharmaceutical AG; Wita Proteomics AG Inc.; Artemis Pharmaceuticals GmbH; Astex Technology; Aviron Inc.; Cellzome AG; Crucell NV; Cubist Stages Funded Pharmaceuticals Inc.; CV Therapeutics Inc.; Cytyc Seed, Series A-B, Series C-D, Mezzanine, Bridge Corporation; deCODE Genetics Inc.; D-Pharm Ltd.; Enanta Pharmaceuticals Inc.; EPIX Medical Inc.; Exelixis Inc.; ILEX Areas of Focus Oncology Inc.; Impliant Ltd.; MDeverywhere Inc.; Med e- Therapeutics, Diagnostics Manager Corporation; MedVantx; Mitotix Inc.; Neurogenetics Inc.; Oridion Systems Ltd.; Osteotech Inc.; Ribozyme Pharmaceuticals Inc.; Stereotaxis Inc.; Telik Inc.; Advent International Advisory SL – Spain Variagenics Inc.; Vernalis plc Velázquez, 140 – 2o Izda Stages Funded Madrid, Spain E-28006 Seed, Series A-B, Series C-D, Mezzanine, Bridge, Buyout Ph: +(34) 917454860 Fax: +(34) 34917454861 Areas of Focus Web: www.adventinternational.com Therapeutics, Vaccines, Diagnostics, Medical devices E-mail: info@es.adventinternational.com Company Contact Diaz-Laviada, Juan Advent International Romania SRL – Romania jlaviada@es.adventinternational.com 7 Intrarea Polona Street Bucharest, Romania Sector 1 Ph: +(40) 212111602 Advent International GmbH – Germany Fax: +(40) 212111602 Web: www.adventinternational.com Westhafenplatz 6 E-mail: info@ro.adventinternational.com Frankfurt am Main, Germany D-60327 Ph: +(49) 699552700 Company Contact Fax: +(49) 6995527020 Popa-Radu, Emma Web: www.adventinternational.com epoparadu@uk.adventinternational.com E-mail: info@de.adventinternational.com Company Contacts Huep, Ralf Advent International SARL – France General Manager 55 Avenue Hoche rhuep@germany.adventinternational.com Paris, France F-75008 Ph: +(33) 155372900 Spinner, Thomas Fax: +(33) 155372929 Investment Consultant Web: www.adventinternational.com tspinner@germany.adventinternational.com E-mail: info@fr.adventinternational.com Company Contact Mouradian, Rudolf rmouradian@france.adventinternational.com 4 BioAbility® and BioWorld®
  • 5. 2005 Biotechnology Venture Capital Guide Advent International SRL – Italy AGF Private Equity Via Marina, 6 11 rue Scribe Milan, Italy I-20121 Paris, France F-75425 Ph: +(39) 27712981 Ph: +(33) 158185656 Fax: +(39) 277129888 Fax: +(33) 142655681 Web: www.adventinternational.com Web: www.agfprivatequity.com E-mail: info@it.adventinternational.com E-mail: contact@agfprivatequity.com Company Contact Company Contacts Caporello, Arabella Droller, Rémi Senior Associate Investment Executive acaporello@italy.adventinternational.com Ory-Lavollée, Laure Stages Funded Consultant in Biotechnologies Mezzanine, Bridge, Buyout Biotechnology Portfolio Alchimer; Aptanomics; BMD; Cellectis SA; Diatos SA; Advent Venture Partners ExonHit Therapeutics; Faust Pharmaceuticals; IntegraGen SA; Meristem Therapeutics; Neurotech SA; SpineVision 25 Buckingham Gate London, United Kingdom SW1E 6LD Stages Funded Ph: +(44) 2079322100 Series C-D Fax: +(44) 2078281474 Web: www.adventventures.com Areas of Focus E-mail: info@adventventures.com Therapeutics, Vaccines, Diagnostics, Medical devices, Platform technologies Company Contacts Benjamin, Jerry Partner AIG Private Equity Ltd. Lee, Patrick Baarerstrasse 8 Partner Zug, Switzerland CH-6300 Ph: +(41) 417107060 Malik, Shahzad Fax: +(41) 417107064 Partner Web: www.aigprivateequity.com E-mail: info@aigprivateequity.com Liang, Michael Associate Company Contact Schneider, Conradin Biotechnology Portfolio Manager, Investor Relations Avidex Ltd.; CardiacAssist Inc.; DNA Research Innovations C.Schneider@aigprivateequity.com Ltd.; Infinity Pharmaceuticals; Inpharmatica Ltd.; KuDOS Pharmaceuticals Ltd.; MetaPhore; Micromet AG; Biotechnology Portfolio Microscience; Oxagen Ltd.; Phoqus Pharmaceuticals; Avalon Pharmaceuticals Inc.; Cognetix Inc.; Fresenius PowderMed; Predicant; Santarus; Targacept; Upstate; Medical Care AG; NexRay Inc.; MediSpectra Inc.; Vernalis plc Theravance Inc. Stages Funded Stages Funded Series A-B, Series C-D Seed, Series A-B, Series C-D, Mezzanine, Buyout Areas of Focus Therapeutics, Vaccines, Diagnostics, Medical devices, Platform technologies, Chemicals/reagents/supplies BioAbility® and BioWorld® 5
  • 6. 2005 Biotechnology Venture Capital Guide Aktiva Group DOO Alice Ventures SRL World Trade Center Dunajska Cesta 156 Piazzale F. Baracca, 1 Ljubljana, Republic of Slovenia SL-1000 Milan, Italy I-20123 Ph: +(386) 15604600 Ph: +(39) 24998171 Fax: +(386) 15604650 Fax: +(39) 248517583 Web: www.aktiva-group.si Web: www.aliceventures.it E-mail: natasa.pirc@aktiva-group.si E-mail: info@aliceventures.it Company Contact Company Contact Musar, Ales Gonzalez, John Project Manager john@aliceventures.it ales.musar@aktiva-group.si Biotechnology Portfolio Stages Funded AdProTech Ltd.; Arakis Ltd.; BioWisdom; BrainsGate; Seed, Series A-B CeNeS Pharmaceuticals plc; E*MAZE Networks S.p.A.; Mazor Surgical Technologies; NiTi Alloys Technologies; Onyvax; PanTherix Ltd. Albany Venture Managers Ltd. Stages Funded Forth House, 28 Rutland Square Seed, Series A-B Edinburgh, United Kingdom EH1 2BW Ph: +(44) 1312216510 Fax: +(44) 1312216511 Alpha Trust Web: www.albanyventures.co.uk E-mail: info@albanyventures.co.uk 36 Amalias Avenue Athens, Greece GR-10558 Company Contacts Ph: +(30) 103362100 Steedman, Lindsay Fax: +(30) 103319048 Office Manager Web: www.alphatrustinnovation.gr lindsay.steedman@albanyventures.co.uk E-mail: info@alphatrust.gr Abbott, Raymond Company Contact Managing Director Christoyannis, John raymond.abbott@albanyventures.co.uk Stages Funded Morrison, John Seed, Mezzanine, Buyout Director john.morrison@albanyventures.co.uk Alpha Ventures AE Biotechnology Portfolio Dencare Management Group Ltd.; Domantis Ltd.; 5 Merlin Street IndigoVision Group plc; Meridian Technique Ltd.; Oasis Athens, Greece GR-10671 Healthcare plc; Pharmagene; Xention Discovery Ltd. Ph: +(30) 2103627710 Fax: +(30) 2103619532 Stages Funded Web: www.alphafinance.gr Series A-B E-mail: mail@alphavc.gr Areas of Focus Company Contact Therapeutics, Vaccines, Diagnostics, Medical devices, Vernikos, Pantelis Platform technologies Biotechnology Portfolio Cephalonian Fisheries; Hellenic Mushroom Farm; Micrel S.A.; Star Foods Stages Funded Seed, Series A-B, Series C-D, Mezzanine, Bridge, Buyout Areas of Focus Medical devices, Agriculture 6 BioAbility® and BioWorld®

×